Is this you? Create Your Porfile
Avatar

R. Sanchez

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where R. Sanchez is active.

Explore More

Publication

Featured researches published by R. Sanchez.

European Neuropsychopharmacology | 2014

P.3.d.037 Effects of aripiprazole once-monthly in patients with schizophrenia switched from oral antipsychotics to aripiprazole once-monthly

John M. Kane; C. Zhao; B. Johnson; Ross A. Baker; Anna Eramo; Robert D. McQuade; A. Duca; R. Sanchez; T. Peters-Strickland

European Neuropsychopharmacology | 2014

P.3.d.046 Switching from oral antipsychotics to aripiprazole once-monthly in a naturalistic setting: hospitalisation rates from a mirror study

John M. Kane; C. Zhao; B. Johnson; Ross A. Baker; Anna Eramo; Robert D. McQuade; A. Duca; R. Sanchez; T. Peters-Strickland

European Neuropsychopharmacology | 2014

P.3.d.040 Previous oral aripiprazole dose (10 or 30 mg/day): effect on the efficacy and tolerability of aripiprazole once-monthly

Anna Eramo; Ross A. Baker; A.G. Nylander; L.F. Tsai; T. Peters-Strickland; R. Sanchez

European Neuropsychopharmacology | 2014

P.3.d.035 Aripiprazole once-monthly for long-term maintenance treatment of schizophrenia: a 52-week open-label study

T. Peters-Strickland; Ross A. Baker; Robert D. McQuade; N. Jin; Anna Eramo; P. Perry; B. Johnson; A. Duca; R. Sanchez

European Neuropsychopharmacology | 2014

P.3.d.033 The effects of aripiprazole once-monthly on the PANSS Marder factors in the treatment of patients with schizophrenia

Ross A. Baker; Anna Eramo; L.F. Tsai; T. Peters-Strickland; R. Sanchez

European Neuropsychopharmacology | 2014

P.3.d.034 Effects of aripiprazole once-monthly on functioning in patients with schizophrenia

John M. Kane; C. Zhao; B. Johnson; Ross A. Baker; Anna Eramo; Robert D. McQuade; A. Duca; R. Sanchez; T. Peters-Strickland

European Neuropsychopharmacology | 2013

P.3.d.027 Aripiprazole once-monthly for schizophrenia: a double-blind, randomised, non-inferiority study versus oral aripiprazole

T. Peters-Strickland; W. Wolfgang Fleischhacker; R. Sanchez; N. Jin; Ross A. Baker; B. Johnson; J.Y. Loze; Robert D. McQuade; William H. Carson; John M. Kane

European Neuropsychopharmacology | 2013

P.3.d.037 Hospitalization rates in patients switched from oral antipsychotics to aripiprazole once-monthly for schizophrenia

John M. Kane; J. Zhao; Ross A. Baker; Anna Eramo; Robert D. McQuade; R. Sanchez; T. Peters-Strickland

European Neuropsychopharmacology | 2013

P.3.d.028 Personal and social performance in schizophrenia: double-blind, non-inferiority study of once-monthly vs oral aripiprazole

W. Wolfgang Fleischhacker; R. Sanchez; N. Jin; T. Peters-Strickland; B. Johnson; Anna Eramo; J.Y. Loze; Robert D. McQuade; William H. Carson; John M. Kane

European Neuropsychopharmacology | 2012

P.3.c.018 A placebo-controlled study of efficacy/safety of aripiprazole intramuscular depot for long-term maintenance treatment of schizophrenia

R. Sanchez; P. Perry; N. Jin; B. Johnson; R.A. Forbes; Robert D. McQuade; William H. Carson; W. Wolfgang Fleischhacker; John M. Kane

Explore More

Collaboration

Dive into the R. Sanchez's collaboration.

Top Co-Authors
Avatar

Robert D. McQuade

Princeton University

View shared research outputs
Top Co-Authors
Avatar

John M. Kane

Albert Einstein College of Medicine

View shared research outputs
Top Co-Authors
Avatar

Ross A. Baker

Princeton University

View shared research outputs
Top Co-Authors
Avatar

Anna Eramo

Lundbeck

View shared research outputs
Top Co-Authors
Avatar

William H. Carson

Princeton University

View shared research outputs
Top Co-Authors
Avatar

W. Wolfgang Fleischhacker

Innsbruck Medical University

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge